Literature DB >> 22136526

Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis.

Kevin O Leslie1.   

Abstract

CONTEXT: Idiopathic pulmonary fibrosis is a progressive, fatal lung disease occurring in older individuals. Despite 50 years of accrued data about the disease, little progress has been made in slowing functional loss or in decreasing patient mortality.
OBJECTIVE: To present a novel hypothesis on the etiology and pathogenesis of idiopathic pulmonary fibrosis.
DESIGN: Published data are reviewed regarding the epidemiology, clinical presentation, natural history, radiologic findings, and pathologic findings in patients with idiopathic pulmonary fibrosis.
RESULTS: Patients with idiopathic pulmonary fibrosis may be predisposed genetically to tractional injury to the peripheral lung. The result is recurrent damage to the epithelial-mesenchymal interface, preferentially at the outer edges of the basilar lung lobules where tractional stress is high during inspiration, compliance is relatively low, and there is a greater tendency for alveolar collapse at end-expiration. A distinctive "reticular network of injury" (the fibroblast focus) forms, attended by a prolonged phase of wound repair (tear and slow repair). Discrete areas of alveolar collapse are observed in scar at the periphery of the lung lobules. The cycle repeats over many years resulting in progressive fibrous remodeling and replacement of the alveoli in a lobule by bronchiolar cysts surrounded by scar (honeycomb lung). Abnormalities in surfactant function are proposed as a potential mechanism of initial lung damage. Age of onset may be a function of a required threshold of environmental exposures (eg, cigarette smoking) or other comorbid injury to the aging lung.
CONCLUSIONS: Evidence supporting this hypothesis is presented and potential mechanisms are discussed. A potential role for contributing cofactors is presented.

Entities:  

Mesh:

Year:  2011        PMID: 22136526     DOI: 10.5858/arpa.2011-0511-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  38 in total

1.  Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis.

Authors:  Sydney B Montesi; Rohan Rao; Lloyd L Liang; Hannah E Goulart; Amita Sharma; Subba R Digumarthy; Barry S Shea; Ravi T Seethamraju; Peter Caravan; Andrew M Tager
Journal:  Eur Respir J       Date:  2018-05-17       Impact factor: 16.671

Review 2.  Is Progression of Pulmonary Fibrosis due to Ventilation-induced Lung Injury?

Authors:  Richard K Albert; Bradford Smith; Carrie E Perlman; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 3.  Ageing and the epidemiology of multimorbidity.

Authors:  Miguel J Divo; Carlos H Martinez; David M Mannino
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

Review 4.  Using electron microscopes to look into the lung.

Authors:  Matthias Ochs; Lars Knudsen; Jan Hegermann; Christoph Wrede; Roman Grothausmann; Christian Mühlfeld
Journal:  Histochem Cell Biol       Date:  2016-09-29       Impact factor: 4.304

5.  Variants in angiopoietin-2 (ANGPT2) contribute to variation in nocturnal oxyhaemoglobin saturation level.

Authors:  Heming Wang; Brian E Cade; Han Chen; Kevin J Gleason; Richa Saxena; Tao Feng; Emma K Larkin; Ramachandran S Vasan; Honghuang Lin; Sanjay R Patel; Russell P Tracy; Yongmei Liu; Daniel J Gottlieb; Jennifer E Below; Craig L Hanis; Lauren E Petty; Shamil R Sunyaev; Alexis C Frazier-Wood; Jerome I Rotter; Wendy Post; Xihong Lin; Susan Redline; Xiaofeng Zhu
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

Review 6.  Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.

Authors:  Francisco Paulin; Tracy J Doyle; Elaine A Fletcher; Dana P Ascherman; Ivan O Rosas
Journal:  Rev Invest Clin       Date:  2015 Sep-Oct       Impact factor: 1.451

7.  Microscopic organizing pneumonia and cellular non-specific interstitial pneumonia are widespread in macroscopically normal-appearing lung tissue in idiopathic pulmonary fibrosis.

Authors:  Nevins W Todd; Jeffrey R Galvin; Ashutosh Sachdeva; Irina G Luzina; Sergei P Atamas; Allen P Burke
Journal:  J Heart Lung Transplant       Date:  2016-07-27       Impact factor: 10.247

8.  Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.

Authors:  Joshua K Park; Nathan J Coffey; Steven P Bodine; Charles N Zawatsky; Lindsey Jay; William A Gahl; George Kunos; Bernadette R Gochuico; May Christine V Malicdan; Resat Cinar
Journal:  Am J Respir Cell Mol Biol       Date:  2020-02       Impact factor: 6.914

9.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Authors:  Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron
Journal:  Thorax       Date:  2014-09-12       Impact factor: 9.139

10.  Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.

Authors:  Eun Joo Chung; Grace McKay-Corkum; Su Chung; Ayla White; Bradley T Scroggins; James B Mitchell; Mary Jo Mulligan-Kehoe; Deborah Citrin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-14       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.